Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.01

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, versus $0.01 reported last year. Revenue for the quarter came in at $8.8 million, versus $7.9 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Apple’s big price hike seen as "an unprecedented push to protect margins"